About IRUBIS

IRUBIS GmbH is a Munich-based startup founded by Anja Müller, Alexander Geißler and Lorenz Sykora-Mirle in 2017. IRUBIS has developed Monipa to bring biological drugs faster to the market. This process analytical technology improves process development and manufacturing of biopharmaceuticals. Monipa is a mid-infrared spectrometer system that enables real-time monitoring and control of important parameters in bioprocessing. It’s single-use interface and the simplifying calibration model, revolutionizes the bioprocess industry. Monipa is already in use by key opinion leaders in the biopharma industry.

Press releases

Press
6. October 2022

Real-Time Monitoring of Bioprocesses: IRUBIS closes EUR 2.8m seed round led by HTGF, Verve Ventures and Ventura BioMed Investors

Biotech startup IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene. Munich, 6 October 2022 – IRUBIS was founded in September 2017 by Lorenz Sykora, Alexander Geißler and Anja Müller with the goal to automate the process d
 

Info & Contact

Phone:
+49 89 215 390 16
Anja Müller, Co-founder
Web:
irubis.com

Address

IRUBIS GmbH
Schillerstr. 40B,
80336 München


Sector

 

Dr. Laura Pedroza

Investment Manager